Spine
Judge denies NuVasive in NeuroVision spat, cancels trademark
Baxano: Strong Q2, new patents can’t appease Wall Street
Baxano Surgical (NSDQ:BAXS) just can’t seem to do right by Wall Street.
St. Jude closes $200M NeuroTherm buy
Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.
NuVasive soars on Q2 sales, earnings beats
Press Release: Medtronic receives FDA approval for prestige LP cervical disc system
MEMPHIS, TENN. – Medtronic, Inc. (NYSE: MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System for the treatment of single-level cervical disc disease (radiculopathy and/or myelopathy).
Medtronic lands FDA approval to bring 3rd artificial cervical disc to the U.S.
Study: Mazor touts 99% accuracy in placing screws in youth with scoliosis
FDA dings Spinal Elements for design changes, unreviewed claims
The FDA posted a warning letter against California-based Spinal Elements, saying that the company failed to obtain regulatory clearance for design changes to certain of its intervertebral body fusion devices.
St. Jude drops $200M on NeuroTherm for spinal pain device
Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.